Evaluation of brain serotonin transporter in patients with chronic pain using central nervous system PET

Evaluation of brain serotonin transporter in patients with chronic pain using central nervous system PET - pain-DASB

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059642

Enrollment

Registered

2025-11-05

Start date

2025-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with chronic pain

Exclusion criteria

Exclusion criteria: History of serious physical illness, organic brain disease, or seizure disorder Unsuitable for the MRI environment, such as claustrophobia or wearing devices (cardiac pacemakers, cerebral artery clips, etc.) that are affected by MRI Serious liver or kidney disorders or heart disease that could affect safety evaluation Exposed to more than 15 mSv (millisieverts) of radiation per year due to work-related exposure or radiation therapy Received contrast agents or radiopharmaceuticals within two days of the examination, or who are scheduled to receive such treatment the day after Pregnant women or those who may be pregnant

Design outcomes

Primary

Measure	Time frame
Binding potential of serotonin transporter in the brain using [11C]DASB	—

Countries

Japan

Contacts

Public ContactArakawa Ryosuke

Nippon Medical School Department of Pharmacology

s3006@nms.ac.jp03-3822-2131

Outcome results